Independent. Not owned by or funded by any pharmaceutical manufacturer.
Evidence-sourced · medically-reviewed where indicated
← Back to the full directory
Provider profile · Compounded only

Willow Health

Evidence-sourced
Written and fact-checked to our published editorial standards.Last updated 2026-07-26. Every clinical claim on this page is sourced to a named primary authority, listed at the foot of the page — see how we research, source, and correct our work.

A cash-pay telehealth service built around compounded tirzepatide. Uniquely among the providers Eli Lilly sued in April 2025, Willow Health's case was dismissed in September 2025 — though it separately faced an advertising-standards challenge over its marketing claims.

This is not a review

We have not personally used Willow Health, so we are not rating quality of care, wait times, or customer service. What follows is Willow Health’s own published terms, checked against independent reporting where we found it. See our full methodology on the provider directory.

Resolved

Was a named defendant in Eli Lilly's April 2025 lawsuit over compounded tirzepatide marketing, but a federal judge dismissed the case against Willow Health in September 2025 after Lilly failed to show patients or physicians had switched away from its branded products because of it.

Source: Lengea Law (legal industry coverage)
Caution

Separately, following a challenge from Novo Nordisk, the BBB National Programs' National Advertising Division recommended Willow Health modify or discontinue certain health-related claims made about its compounded semaglutide products.

Source: National Advertising Division referral coverage

At a glance

Access model
Compounded only
Medications offered
Compounded tirzepatide
Prescriber
Telehealth clinicians
Insurance
Cash-pay model; not built around insurance billing
Membership / program fee
Not published in a single, stable price list — confirm at signup
Cash-pay from
Not published in a single, stable price list — confirm at signup
States served
Not published in a single state-coverage list — confirm at signup

On compounding

Built entirely around compounded medication. Compounded drugs are not FDA-approved products in their own right; the FDA does not review compounded formulations for safety, effectiveness, or manufacturing quality the way it does an approved drug.

For the fuller regulatory picture — the pending FDA proposal on 503B compounding and what it does and doesn’t affect — see the explainer on the main directory page.

How to reach Willow Health

Visit Willow Health’s own site to confirm current pricing, state availability, and eligibility — all of the figures above can change without notice, and only the provider itself has the current version.

How this compares

Other providers with a similar access model or worth contrasting against:

Sources

Each source below supports specific statements on this page. We cite the strongest available authority and verify against the current version before publishing.

  1. Willow Health — published termsWillow HealthSupports: Access model, medications, prescriber type, insurance, pricing, and state coverage as stated in this profile.
  2. Was a named defendant in Eli Lilly's April 2025 lawsuit over…Lengea Law (legal industry coverage)Supports: The regulatory or litigation flag noted above.
  3. Separately, following a challenge from Novo Nordisk, the BBB…National Advertising Division referral coverageSupports: The regulatory or litigation flag noted above.

This page is general education, not medical advice. Talk to your own healthcare provider about your situation before starting, stopping, or changing any medication.